Omics in Diabetic Kidney Disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Diabetic Nephropathy

• Publication date

  2018-10-30

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1007/978-3-319-93521-8_28
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

  2017cited by this paper
• Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics.

  2017cited by this paper
• Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy

  2017cited by this paper
• Protein Array-based Approaches for Biomarker Discovery in Cancer

  2017cited by this paper
• miR-21 is associated with fibrosis and right ventricular failure.

  2017cited by this paper
• MicroRNA therapeutics: Discovering novel targets and developing specific therapy

  2016cited by this paper
• Metabolomics in Diabetic Kidney Disease: Unraveling the Biochemistry of a Silent Killer

  2016cited by this paper
• miR-21 promotes fibrosis in an acute cardiac allograft transplantation model.

  2016cited by this paper
• Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis

  2016cited by this paper
• miR-21-5p renal expression is associated with fibrosis and renal survival in patients with IgA nephropathy

  2016cited by this paper
• Renal Biopsy in 2015 - From Epidemiology to Evidence-Based Indications

  2016cited by this paper
• Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

  2016cited by this paper
• MicroRNAs in kidney physiology and disease

  2015cited by this paper
• Detection and quantification of proteins in clinical samples using high resolution mass spectrometry.

  2015cited by this paper
• RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.

  2015cited by this paper
• Renal lesions in patients with type 2 diabetes: a puzzle waiting to be solved.

  2015cited by this paper
• Urinary mRNA levels of ELR‐negative CXC chemokine ligand and extracellular matrix in diabetic nephropathy

  2015cited by this paper
• Renal histologic changes and the outcome in patients with diabetic nephropathy.

  2015cited by this paper
• Analytical Methods in Untargeted Metabolomics: State of the Art in 2015

  2015cited by this paper
• A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications

  2015cited by this paper
• Controlling False Discovery Rate in Signal Space for Transformation-Invariant Thresholding of Statistical Maps

  2015cited by this paper
• Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?

  2014cited by this paper
• Coverage recommendations for methylation analysis by whole genome bisulfite sequencing

  2014cited by this paper
• Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits

  2014cited by this paper
• SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes

  2014cited by this paper
• Uremic solutes and risk of end stage renal disease in type 2 diabetes

  2014cited by this paper
• Diabetic nephropathy—emerging epigenetic mechanisms

  2014cited by this paper
• Technology: The $1,000 genome

  2014cited by this paper
• Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

  2014cited by this paper
• Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development

  2014cited by this paper
• Emerging trends of long non‐coding RNAs in gene activation

  2014cited by this paper
• Regulation of TIMP3 in diabetic nephropathy: a role for microRNAs

  2013cited by this paper
• Towards microRNA-based therapeutics for diabetic nephropathy

  2013cited by this paper
• Circulating microRNAs as novel biomarkers for diabetes mellitus

  2013cited by this paper
• Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice

  2013cited by this paper
• Overview of Protein Microarrays

  2013cited by this paper
• Reflections on univariate and multivariate analysis of metabolomics data

  2013cited by this paper
• From -omics to personalized medicine in nephrology: integration is the key.

  2013cited by this paper
• Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis

  2013cited by this paper
• Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease.

  2013cited by this paper
• Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population

  2013cited by this paper
• The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.

  2013cited by this paper
• MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways

  2012cited by this paper
• Urinary mRNA markers of epithelial–mesenchymal transition correlate with progression of diabetic nephropathy

  2012cited by this paper
• Histone Ubiquitination and Deubiquitination in Transcription, DNA Damage Response, and Cancer

  2012cited by this paper
• Histone phosphorylation

  2012cited by this paper
• An integrated map of genetic variation from 1,092 human genomes

  2012cited by this paper
• A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy

  2012cited by this paper
• Histone methylation: a dynamic mark in health, disease and inheritance

  2012cited by this paper
• Characterization of Glomerular Diseases Using Proteomic Analysis of Laser Capture Microdissected Glomeruli

  2012cited by this paper
• Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy

  2012cited by this paper
• Urinary Podocyte-Associated mRNA profile in Various Stages of Diabetic Nephropathy

  2011cited by this paper
• Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study)

  2011cited by this paper
• DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy

  2011cited by this paper
• An introduction to biological nuclear magnetic resonance spectroscopy

  2011cited by this paper
• Transcriptome Analysis of Human Diabetic Kidney Disease

  2011cited by this paper
• MicroRNA-29c Is a Signature MicroRNA under High Glucose Conditions That Targets Sprouty Homolog 1, and Its in Vivo Knockdown Prevents Progression of Diabetic Nephropathy*

  2011cited by this paper
• Phospholipidomic identification of potential plasma biomarkers associated with type 2 diabetes mellitus and diabetic nephropathy.

  2011cited by this paper
• Plasma esterified and non-esterified fatty acids metabolic profiling using gas chromatography-mass spectrometry and its application in the study of diabetic mellitus and diabetic nephropathy.

  2011cited by this paper
• The use of formalin fixed wax embedded tissue for proteomic analysis

  2011cited by this paper
• Epigenetic phenomena linked to diabetic complications

  2010cited by this paper
• Genetic associations in diabetic nephropathy: a meta-analysis

  2010cited by this paper
• Urine Proteome Analysis May Allow Noninvasive Differential Diagnosis of Diabetic Nephropathy

  2010cited by this paper
• ELMO1 variants and susceptibility to diabetic nephropathy in American Indians.

  2010cited by this paper
• Between a chicken and a grape: estimating the number of human genes

  2010cited by this paper
• Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus

  2010cited by this paper
• Metabolomics Applied to Diabetes Research

  2009cited by this paper
• Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria.

  2009cited by this paper
• Confirmation of Genetic Associations at ELMO1 in the GoKinD Collection Supports Its Role as a Susceptibility Gene in Diabetic Nephropathy

  2009cited by this paper
• An operational definition of epigenetics.

  2009cited by this paper
• Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy.

  2009cited by this paper
• Proteomics by mass spectrometry: approaches, advances, and applications.

  2009cited by this paper
• The non-invasive biopsy--will urinary proteomics make the renal tissue biopsy redundant?

  2009cited by this paper
• Evolving from reductionism to holism: is there a future for systems medicine?

  2009cited by this paper
• Chronic kidney disease prevalence estimates among racial/ethnic groups: the Multi-Ethnic Study of Atherosclerosis.

  2008cited by this paper
• G/T Substitution in Intron 1 of the UNC13B Gene Is Associated With Increased Risk of Nephropathy in Patients With Type 1 Diabetes

  2008cited by this paper
• HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention

  2007cited by this paper
• Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics

  2007cited by this paper
• Recent applications of NMR spectroscopy in plant metabolomics

  2007cited by this paper
• The ECM protein nephronectin promotes kidney development via integrinα 8β1-mediated stimulation of Gdnf expression

  2007cited by this paper
• Lipotoxicity.

  2006cited by this paper
• Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.

  2005cited by this paper
• Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy.

  2004cited by this paper
• Two-dimensional gel electrophoresis: a fundamental tool for expression proteomics studies.

  2004cited by this paper
• Initial sequencing and analysis of the human genome

  2001cited by this paper
• Analysis of proteins and proteomes by mass spectrometry.

  2001cited by this paper
• Electrospray ionization for mass spectrometry of large biomolecules.

  1989cited by this paper
• Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

  1989cited by this paper
• Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

  1988cited by this paper

• A Review of Proteomics Strategies to Study T-Cell Activation and Function in Cancer Disease.

  2021cites this paper
• A sea cucumber (Holothuria leucospilota) polysaccharide improves the gut microbiome to alleviate the symptoms of type 2 diabetes mellitus in Goto-Kakizaki rats.

  2019cites this paper